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Abstract
Actin capping and cross-linking proteins regulate the dynamics and architectures of different cellular protrusions. Eps8 is
the founding member of a unique family of capping proteins capable of side-binding and bundling actin filaments.
However, the structural basis through which Eps8 exerts these functions remains elusive. Here, we combined biochemical,
molecular, and genetic approaches with electron microscopy and image analysis to dissect the molecular mechanism
responsible for the distinct activities of Eps8. We propose that bundling activity of Eps8 is mainly mediated by a compact
four helix bundle, which is contacting three actin subunits along the filament. The capping activity is mainly mediated by a
amphipathic helix that binds within the hydrophobic pocket at the barbed ends of actin blocking further addition of actin
monomers. Single-point mutagenesis validated these modes of binding, permitting us to dissect Eps8 capping from
bundling activity in vitro. We further showed that the capping and bundling activities of Eps8 can be fully dissected in vivo,
demonstrating the physiological relevance of the identified Eps8 structural/functional modules. Eps8 controls actin-based
motility through its capping activity, while, as a bundler, is essential for proper intestinal morphogenesis of developing
Caenorhabditis elegans.
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Introduction
Actin-based motility is involved in many cellular processes
including cell migration, morphogenesis, endocytosis, and cytoki-
nesis [1]. A large number of actin-binding proteins participate in
controlling the architecture and dynamics of the diverse and
versatile actin-based structures that result from these processes.
Among them, capping proteins block the growing ends of actin-
filaments and are essential for the regulation of actin turnover. The
importance of capping proteins in actin motility was demonstrated
by experiments in which actin-based motility could be reconsti-
tuted in vitro, starting from a minimal set of purified components,
in the presence of a capping protein [2,3].
Consistent with such a key role, various types of capping
families have been identified in mammals and considerable effort
has been devoted to explore the structural mechanisms of action.
Capping proteins display a variable and not conserved domain
organization, suggesting different modes through which they cap
actin filaments. The Gelsolin family includes seven actin-binding
proteins, characterized by a variable number of homologous and
repeated Gelsolin domains [4]. Gelsolin itself, for instance,
contains six repeats (G1–G6) of which three are calcium-regulated
PLoS Biology | www.plosbiology.org 1 June 2010 | Volume 8 | Issue 6 | e1000387actin binding-surfaces G1, G2, and G4 [5–8]. Biochemical and
structural studies of the isolated first two domains of Gelsolin, G1–
G2, in complex with monomeric or dimeric actin, indicated that
this assembly is sufficient for capping, with G1 binding the barbed
end of actin and G2 contacting the side of the filament end [7–9].
This mode of interaction is conserved in Twinfilin [10,11], which,
however, has no sequence similarity with Gelsolin. Instead, it
contains two ADF (Actin Depolymerizing Factor) homology
domains, which have been proposed to contact the last two actin
subunits in the filament, in a fashion that resembles the interaction
between gelsolin G1–G2 and actin [10,11]. Finally, the Capping
Protein CP, the most widely distributed cappers in mammalian
cells, is a heterodimer in which the flexible C-terminal regions of
each promoter, a and b, have been proposed to block elongation
of the two terminal actin subunits [12,13].
Eps8 is the prototype of an Eps8L-family of capping proteins
including four related genes in mammals, which possess unique
features among cappers. Eps8L molecules display a modular
domain organization (PTB, SH3 domains and a C-terminal, actin-
binding region) more typically found in signaling adaptors.
Accordingly, Eps8 participates, via its SH3 domain, in the
formation of distinct macromolecular complexes that either
transduce signals from Ras to Rac leading to actin remodeling
or regulate endocytosis of receptor tyrosine kinases [14,15]. The
isolated C-terminal domain (residues 648–821) caps barbed ends
in the nanomolar range, as do most cappers, but it is inhibited in
the context of the full-length protein [16,17]. Binding of Eps8 to
ABI1 relieves this auto-inhibition. Therefore, Eps8 is regulated
somewhat unconventionally for barbed end cappers via a
protein:protein interaction [17]. Remarkably, unlike other cap-
pers, full-length Eps8 has also been shown to organize actin
filaments into higher order structures, and this cross-linking
activity is significantly enhanced in the presence of another
protein:protein interaction, in this case with IRSp53 (Insulin
Receptor Tyrosine Kinases Substrate of 53 KD [18–21]).
Here, we combined biochemical and molecular biology and
genetic approaches with electron microscopy (EM) to dissect the
molecular and structural basis of Eps8 interaction(s) with actin
filaments. We find that an amphipathic helix (H1) is largely
responsible for Eps8 capping activity by blocking the barbed end
of the filament while a compact, globular domain (H2–H5) binds
to the side of filaments and promotes bundling. This bimodal
mechanism of association to actin filaments further permitted us to
define the relative contribution of the two actin related activities of
Eps8 in vivo. Thus, Eps8 controls actin-based motility and
endomembrane cellular trafficking through its capping activity,
while, as a bundler, is essential for proper intestinal morphogenesis
of developing Caenorhabditis elegans.
Results
Eps8 Actin Binding Domain (648–821) Binds and
Sequesters Monomeric Actin
Capping proteins are able to bind and block the barbed end of
actin filaments. In addition, Gelsolin, Twinfilin, and CP can
associate with monomeric actin [22,23]. Similarly, the fluorescence
of NBD-(7-chloro-4-nitrobenzofurazan)-actin was significantly in-
creased (by as much as 20%) by the addition of Eps8 capping
domain, Eps8(648–821), in low ionic strength conditions (G-buffer),
demonstratingits ability to bind monomericactin (Figure S1A). The
intensity of fluorescence depended directly upon the protein
concentration, indicating a saturation binding mode, consistent
with the formation of a 1:1 complex between monomeric actin and
Eps8(648–821) with an equilibrium dissociation Kd of around
50 nM, when measured at low ionic strength conditions (G-buffer)
(Figure 1A, 1H),and around1.7 mM, when physiological conditions
(F-Buffer) were used (Figure 1B–1H). We confirmed the 1:1 ratio of
the Eps8(648–821):G-actin complex through chemical cross-linking
and size-exclusion chromatography experiments. In the first
approach, we detected a single covalently cross-linked protein with
a size of ,60 KD, equivalent to the sum of the molecular weights of
Eps8(648–821) and monomeric actin (Figure 1C). By gel filtration
analysis, Eps8(648–821) and G-actin eluted in distinct fractions,
according to their respective molecular weight (Figure 1D).
Conversely, when mixed in a 1:1 molar ratio, they co-fractionated,
forming a stoichiometric complex (Figure 1D). Addition of 2-fold
molar excess of Eps8(648–821) saturated the amounts of G-actin
and the excess of the former eluted with the expected retention
volume (Figure 1D). Finally, submicromolar (at low ionic strength)
to micromolar (at physiological ionic strength) Kd values were
obtained for ADP-G-actin, indicating that Eps8(648–821) binds
both nucleotide-bound forms of actin with similar affinity
(Figure 1E, 1H).
Several G actin-binding domains, such as WH2 (WASp
Homology 2) and ADF homology domains, decrease the
nucleotide dissociation rate from G-actin, while others, like
profilin, enhance it. Among the capping proteins, Twinfilin
inhibits nucleotide exchange from ADP-G-actin [24], whereas
gelsolin, which forms a ternary complex with two actin subunits,
blocks nucleotide exchange from the ATP-bound G-actin
[5,25–28]. We thus tested the effect of Eps8(648–821) on
nucleotide exchange by monitoring the association of a fluorescent
e-ATP analogue to ATP-G-actin. At low ionic strength, Eps8(648–
821) significantly diminished the nucleotide exchange rate on G-
actin by 5-fold, similarly to what has been reported for the WH2
domain of Ciboulot (Figure 1F) [29]. These results suggest that the
Eps8(648–821):G-actin complex shares biochemical and, likely,
structural features with G-actin in complex with either WH2
domains, S1-gelsolin, or Twinfilin.
The formation of an Eps8(648–821):G-actin complex prompted
us to revisit the effect of Eps8(648–821) on actin assembly. We
Author Summary
One of the key components of the cytoskeleton of cells is
actin, which allows cells to move. Actin-based motility is
involved in many biological processes, such as intestinal
development, intracellular trafficking and cell migration.
Actin monomers are individual building blocks that can be
linked together to form actin filaments. Numerous actin-
binding proteins are involved in controlling the higher
order architecture and dynamics of these actin filaments
within cells. For example, actin capping proteins regulate
actin dynamics by controlling the number of growing
filament ends, and actin cross-linking or bundling proteins
determine how to organize these filaments into higher
order structures. The protein Eps8 is capable of capping as
well as bundling actin filaments. However, the structural
basis of this dual role of Eps8 remains unknown. In this
study, we use a combination of techniques to unravel the
molecular and structural basis of Eps8 interactions with
actin filaments. We show that distinct structural modules
of Eps8 are responsible for capping versus bundling
activity, and we determine the contributions of these
modules in vitro and in vivo. At the functional level, we
find that Eps8 regulates actin-based motility and cellular
trafficking through its capping activity, whereas
Eps8-mediated bundling is essential for intestinal
morphogenesis.
Eps8 Caps and Bundles by Wrapping around F-Actin
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increasing concentration of Eps8(648–821). For this purpose, we
used spectrin-actin seeds, which are purified oligomers of actin and
Spectrin with blocked pointed, but free barbed, ends. As
previously reported, Eps8(648–821) inhibited the filament barbed
end linear elongation rate in a dose-dependent manner with
nanomolar affinity (Kcap=15 nM); inhibition occurred at concen-
tration that were substoichiometric with respect to G-actin
(Figure 1G). Eps8(648–821) also inhibited, in a concentration-
dependent fashion, actin polymerization in gelsolin-seeded growth
assays, which permit measurement of the elongation rate of
filaments exclusively from pointed ends. In this latter case,
however, stoichiometric concentrations of Eps8(648–821) with
respect to G-actin were required, with an apparent Ki (Constant of
inhibition) of Eps8(648–821) for pointed end filament growth of
around 2.5 mM (Figure 1G–1H), in good agreement with the Kd
of the Eps8(648–821):G-actin complex measured at physiological
salt conditions (Figure 1B, 1H). Under these conditions, an
Eps8(648–821):G-actin complex is formed that cannot be
incorporated into nascent filament; the complex thus fails to
support pointed end growth, and this is reflected in the
sequestration of monomeric actin.
The Minimal G-Actin Binding and Capping Region of
Eps8(648–821) Encompasses Its Amphipathic (H1) Helix
Eps8 barbed end capping activity is encoded by its evolution-
arily conserved, C-terminal region (residues 648–821 for murine
Eps8) (Figure S1B). This region displays no sequence similarity
with other known capping proteins or actin-binding motifs.
However, prediction of its secondary structure indicated that it is
composed of five alpha helices (H1 to H5 from N- to C-terminus)
connected by linkers of variable length.
In order to define the binding surfaces of the C-terminal region
of Eps8 with actin, various fragments encompassing different
helices, alone or in combination, were purified and assayed for
actin binding using the fluorescence of NBD-actin as a probe
(Figure 2A and Figure S1C). The helices H1–H2 (residues 674–
737) and the isolated predicted H5 (residues 765–788) (Figure
S1D) were the minimal fragments capable of increasing NBD-
actin fluorescence by 17% and 12%, respectively (Figure S1E), and
were further characterized. Determination of the affinity constants
of dissociation revealed that the two fragments bound with
significantly different affinity parameters. H1–H2 displays a much
higher affinity (Kd=50 nM) for monomeric actin than the isolated
H5 (Kd=3 mM) (Figure 2B, 2C, and 2G). The existence of a 1:1
complex between G-actin and Eps8(648–821) suggests the
possibility that this region of Eps8 may bind one actin monomer
through two different surfaces. This, however, appears unlikely
since, as predicted by avidity, the overall interaction affinity of
Eps8(648–821), which possesses two actin binding sites, would be
in the picomolar rather than in the nanomolar range as
experimentally determined (Figure 1A). Thus, we conclude that
the H1–H2 helices represent the major surface of interaction
within the Eps8(648–821):G-actin complex.
Next, we tested the effect of the formation of the G-actin:H1–
H2 and G-actin:H5 complexes on actin dynamics at the two ends
of actin filaments. H1–H2 inhibited growth completely at both
ends of actin filaments in a saturable fashion. Substoichiometric
concentrations of H1–H2 to G-actin were required to reduce
barbed end growth, with a calculated Kcap of ,200 nM suggesting
that these isolated helices are critical in mediating barbed end
capping (Figure 2D). However, the significantly reduced affinity of
H1–H2 (Kcap=200 nM) with respect to Eps8(648–821) (Kcap=1–
15 nM) indicates that other structural determinants contribute to
full capping activity and barbed end binding. Sequestration of
ATP-G-actin by HI–H2, instead, completely accounted for the
concentration-dependent inhibition of pointed ends growth, in a
stoichiometric range of concentrations with respect to G-actin,
with a Kseq of 2.5 mM, identical to that calculated for the
Eps8(648–821) (Figure 2D, 2G).
We performed the same set of assays for the isolated H5. H5
inhibited filament growth from either pointed or barbed ends in a
concentration-dependent fashion. In both cases, however, the
thermodynamic parameters of inhibition were in the micromolar
range (Kdpointed=32mM; Kdbarbed=40mM) (Figure 2E, 2G),
indicating that supra-stoichiometric amounts of H5 were required
to block filament end growth, consistent with a low sequestering
activity. To provide additional evidence that low affinity binding
Figure 1. Eps8(648–821) binds monomeric actin and inhibits ATP-dissociation from ATP-Ca-G-Actin. (A–B) Eps8(648–821) binds
monomeric actin. The change in fluorescence of NBD-labeled-actin was measured at different concentrations of Eps8(648–821), in either (A) low salt
(G-buffer) or (B) in high salt (F buffer) buffer containing 0.1 M KCl and 1 mM MgCl2. Symbols indicate data; solid line indicates fitted binding curve for
a complex with a 1:1 stoichiometry. The curve is calculated using Equation 1 in the ‘‘Experimental Procedure.’’ (C–D) Eps8(648–821) forms a 1:1
complex with actin. (C) Chemical cross-linking revealed that Eps8(648–821) and actin form a 1:1 complex. Eps8(648–821) and actin, either alone or in
combination, were incubated for various lengths of time in the absence or presence of PPDM, separated by SDS-PAGE and detected by Coomassie
blue staining. Lanes 1, 2, 3: 10 mM of Eps8(648–821) incubated in the absence (Lane 1) or the presence of the cross-linker for 5 min (Lane 2) or 15 min
(Lane 3); Lanes 4, 5, 6: 10 mM of actin alone incubated in the absence (Lane 4) or the presence of PPDM for 5 min (Lane 5) and 15 min (Lane 6); Lanes
7, 8, 9: 10 mM of Actin (10 mM) and Eps8(648–821) incubated in the absence (Lane 7) or the presence of PPDM for 5 (Lane 8) and 15 (Lane 9) min.
Molecular weight markers are also shown and indicated on the right. (D) Eps8 C-terminal domain and Actin co-elute in gel filtration forming a 1:1
complex. Size exclusion chromatography experiment on a Superdex 200 10/30 column in G buffer (2 mM TRIS pH 7.8, 0.2 mM ATP, 1 mM DTT,
0.1 mM CaCl2). Purified Actin and Eps8(648–821) were analyzed by gel filtration either alone (blue and black line, respectively) or after pre-incubation
on ice for 1 h in a 1:1 or 1:2 molar ratio (red and green line, respectively). In each case, 30 uL fractions were collected and analyzed by Coomassie
staining on 10% SDS-PAGE gel, which is shown beneath the elution profile. (E) Eps8(648–821) binds ATP- and ADP-G-actin with similar affinities. The
change in fluorescence of 1.5 mM NBD-ADP-G-actin (blue line, closed squares) or NBD-ATP-G-actin (red line, closed circles) was measured at different
concentrations of Eps8(648–821), in G-buffer. ATP to ADP exchange was performed using Hexokinase in the presence of 10 mM MgCl2 and 1 mM
glucose. Symbols indicate data; solid lines indicate fitted binding curves for a complex with 1:1 stoichiometry. The affinity constants calculated from
these plots using the equation described in the Materials and Methods section were Kd(ATP-Ca-G-Actin) =75 nM, Kd(ADP-Ca-G-Actin) =125 nM. (F)
Eps8(648–821) inhibits the dissociation of ATP from ATP-G-Actin. ATP-G-actin (2 mM, in G-buffer containing 20 mM of CaCl2) was supplemented with the
indicated concentrations of Eps8(648–821). The dissociation of bound ATP was monitored by adding 5 mMo feATP at time 0 and recording the
subsequent increase of fluorescence of eATP. The pseudo-first order exchange rate constant is plotted versus the total concentration of Eps8(648–
821). (G) Barbed and pointed end elongation rate of actin in the presence of Eps8(648–821). The rate of elongation was measured from pointed ends
(circles), using gelsolin-actin seeds (5 nM) and 2 mM of G-actin (10% pyrenyl-labeled), or from barbed ends (triangles) using spectrin-actin seeds, in
the presence of increasing concentrations of Eps8(648–821), as indicated. Rates are normalized taking as 100% the rate of elongation from either
pointed or barbed ends measured in the absence of Eps8(648–821). (H) Summary of the equilibrium parameters for binding of Eps8(648–821) to
monomeric actin measured under the different conditions and methodology indicated above.
doi:10.1371/journal.pbio.1000387.g001
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performed pointed end assays at two concentrations of G-actin.
Higher concentrations of H5 were required to inhibit barbed end
growth when the concentrations of G-actin was increased from 2
to 4 mM, accounting for the shift toward the right of the curves
(Figure 2F); this result demonstrates that the inhibition by the
isolated H5 is solely dependent on its ability to sequester
monomeric actin and is not due to low affinity binding to filament
ends.
Collectively, these data indicate that Eps8(648–821)’s actin-
binding surface comprises two binding surfaces, H1–H2 and H5.
Only the isolated H1–H2 displays significant barbed end capping
activity. This result underlines the importance of the integrity of
these helices for this function, a notion that further accounts for
previous findings indicating that mutations in key amino acid
residues in H2 significantly impaired capping [30]. Instead, both
H1–H2 and H5 can associate with monomeric actin, albeit with
different affinities, both contributing to barbed end capping in the
context of the full-length protein.
The Amphipathic (H1) Helix of Eps8 Contacts the
Hydrophobic Pocket between Subdomain 1 and 3 of
Actin
We employed two independent approaches to identify residues
involved in binding between actin and Eps8(648–821). In the first
approach, we performed competition binding assays between
NBD-actin and Eps8(648–821) in the presence or absence of
saturating concentrations of either Ciboulot or Thymosin b4o r
ADF cofilin, which bind between subdomains 1 and 3 of actin, at
the barbed end [27,31]. NBD-G-actin saturated with Thymosin
b4 or Ciboulot displayed levels of fluorescence significantly higher
than NBD-G-actin either alone or in complex with Eps8(648–821)
(Figure 3A, 3B) [29]. The addition of increasing concentrations of
Eps8(648–821) to either Thymosinb4:NBD-G-actin or Cibou-
lot:NBD-G-actin led to a decrease in fluorescence to levels
consistent with the displacement of these proteins from actin and
the concomitant formation of a Eps8(648–821):actin complex
(Figure 3A–B, 3G). Similarly, Eps8(648–821) competed with
ADF/cofilin for binding to ADP-G-actin. Binding of ADF/cofilin
did not significantly affect the fluorescence of NBD-ADP-actin but
caused a large increase in the apparent Kd for binding of
Eps8(648–821) (Figure 3C). Thus, Eps8(648–821) competes with
Thymosin b4, Ciboulot, and ADF/cofilin for binding to
monomeric actin, suggesting that the three proteins share the
same interaction surfaces. Similar assays were performed utilizing
Ciboulot and either the isolated H1–H2 or H5. Only H1–H2, but
not H5, displaced Ciboulot from actin (Figure 3D, 3E). We
obtained similar results using Thymosin b4, Eps8(648–821), H1–
H2, and 5-(2((acetyl)amino)ethyl)amino-naphthalene-1-sulfonate
(AEDANS)-labeled-G-actin in high salt buffer (Figure S2A, S2B).
Thus, collectively, these results indicate that H1–H2 and H5 bind
actin on different surfaces. Consistently, H1–H2 bound NBD-G-
actin with identical affinity in the absence or presence of H5, at
low ionic strength (Figure 3F, 3G). Notably, the increases in
fluorescence of NBD-actin due to the binding of H5 and of H1–
H2 are additive, consistent with simultaneous binding of the two
fragments (Figure 3F). Thus, Eps8(648–821) appears to interact
with two distinct actin surfaces, one of which, the high-affinity
interaction region (H1–H2), is essential for capping and is located
between subdomains 1 and 3 of G-actin. Ciboulot, Thymosin b4,
and ADF cofilin contact this hydrophobic pocket by inserting an
amphipathic helix [32]. Eps8 may adopt a similar mode of binding
since helical wheel analysis showed that the H1 amphipathic helix
exposes conserved hydrophobic residues exposed on a line on one
side (Figure 3E), while the rest of the helix contains a mixture of
different charges. This arrangement is very reminiscent of the
other known helices that bind the hydrophobic cleft of actin
(Figure 3E).
To obtain direct validation of our finding, we performed a
chemical cross-linking experiment followed by mass spectrometry
identification of the resulting hybrid peptides. We generated
isopeptide bonds between side chains of actin and Eps8(648–821)
by incubating these proteins alone, as a control, or in combination
with a cross-linking agent (see Materials and Methods). SDS-
PAGE separation of the resulting reaction products revealed two
slower-migrating protein species, only when Eps8(648–821) and
actin were simultaneously present in the cross-linking mixture
(Figure 4A). We isolated these products and subjected them to
mass spectrometry analysis (Figure 4B). A number of Eps8-actin,
cross-linked peptides could be identified (Figure 4B, right). All
actin-derived peptides contained either K330, located in sub-
domain 3, or K375, located in subdomain 1 (Figure 4C), whereas
Eps8-derived fragments contained K675 and K683, which are
located just before or in the predicted H1, respectively, or K707,
located in the linker region connecting the predicted H1 and H2.
These results are in good agreement with our biochemical
mapping, strengthening the importance of H1–H2 helices in
mediating a tight association of Eps8 with monomeric actin.
Additionally, and more importantly, they suggest that H1–H2 by
interacting in close proximity with subdomains 1 and 3 of actin,
which are the exposed domains on barbed ends of actin filaments,
block the further addition of monomer accounting for their
capping activity (Figure 2). Notably, one cross-linked peptide
isolated from the slower migrating band is the result of an
intramolecular interaction within Eps8(648–821), occurring be-
tween H1 and the linker region, thus suggesting the possibility that
these regions of Eps8 may fold one over the other in a
Figure 2. Eps8(648–821) possess two monomeric actin binding surfaces: H1–H2 and H5. (A) A schematic representation of the secondary
structure organization of Eps8 actin binding domain. H1, H2, H3, H4, and H5 indicate stretches of amino acids that adopt an helical conformation; L1 is
the 20 amino acid-long linker connecting H1 to H2 (see for additional details and amino acids sequence Figure S1B and S1C). (B, C) H1–H2 and H5 bind
G-actin in a concentration-dependent manner. The change in fluorescence of 1.5 mM NBD-labeled-actin was measured at different concentrations of
either H1–H2 (B) or H5 (C), in low salt (G buffer). Symbols indicate data; solid lines indicate fitted binding curves for a complex with 1:1 stoichiometry.
(D, E) H1–H2 and H5 inhibit barbed and pointed end elongation rates with different thermodynamic constants. The rate of elongation was measured
from pointed ends (circles), using gelsolin-actin seeds (5 nM) and 2 mM of G-actin (10% pyrenyl-labeled), or from barbed ends (triangles), using
spectrin-actin seeds (2 nM), in the presence of increasing concentrations of H1–H2 (D) or H5 (E), as indicated. Rates are normalized taking as 100% the
rate of elongation measured in the absence of H1–H2 or H5. Kds are reported in the text. (F) H5 sequesters G-actin but does not cap filaments ends. The
rate of elongation from barbed ends was measured using actin seeds and 2 mM (closed triangles) or 4 mM (opened triangles) of G-actin (10% pyrenyl-
labeled) in the presence of increasing concentrations of H5. A shift toward the left of the rate of elongation by H5 as the concentration of G-actin
used increased indicates that stoichiometric concentrations of H5 with respect to actin are required for the inhibition. (G) Summary of the equilibrium
parameters for binding of H1–H2 and H5 to monomeric actin. The values were obtained as described in the methods from the experimental curves
show in (A–F). Please note that the Kd obtained from the inhibition of pointed end growth experiments reflects the binding affinity of the tested
helices for monomeric actin leading to its sequestration and were performed at physiological salt condition.
doi:10.1371/journal.pbio.1000387.g002
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capping, as observed in the case of full-length Eps8, which displays
no capping activity.
H1 Is Connected to the H2–H5 Globular Core via a
Cleavable Linker
To gain insight into the structural organization of murine Eps8
capping domains we took advantage of the recently solved NMR
structure of the C-terminal region of human Eps8L2 (residues
612–697, 1WWU), a member of the Eps8L family protein [33],
and of human Eps8 (residues 699–784, 2E8M) (Figure 5A),
deposited in the PDB database (Structural Genomic Program–
RIKEN Genomic Sciences Center, Yokohama, Japan). These
fragments, which include the most C-terminal four helices, H2 to
H5 (Figure S1B), fold into a globular, helical core (Figure 5A).
Notably, murine and human Eps8 C-terminal actin binding
domains are nearly identical predicting that they adopt a similar
fold. Structural atomic modeling using the Phyre software (Protein
Homology/Analogy Recognition Engine) confirmed this predic-
tion (Figure 5A). Conversely, the absence of experimental
structural information on the first a-helix of Eps8 and Eps8L2
prevented modeling the folding of this helix with respect to the
globular core. This region of Eps8 appears connected to the core
helical bundle by an unstructured and presumably flexible linker
of 20 residues (Figure S1B). This latter notion is supported by the
observation that in the more closely related ESP8 and EPS8L2
NMR structures (PDB ids 2E8M, 1WWU), the linker is in a
disordered state and not part of the compact core (Figure 5A and
unpublished data). Additionally, limited proteolysis of Eps8(648–
821) resulted in the generation of a fragment encompassing the
proteolytic-resistant, helical globular core, which is thus connected
by an exposed, cleavable linker to H1 (Figure S2C).
The Eps8 Actin Binding Domain Wraps Around Actin
Filaments
Next, we employed a combination of electron microscopy,
three-dimensional (3D) image reconstruction and modeling to
structurally characterize Eps8 binding to actin filaments.
A 3D reconstruction of murine Eps8-bound to F-actin was
generated using a hybrid approach that combines helical
symmetry of actin filaments and real-space images [34,35]. We
used a larger fragment, Eps8(535–821), containing in addition to
the minimal actin-binding and capping region (648–821), also the
SH3 domain (535–586) of Eps8 (Figure 5B). The SH3 domain is
connected by an unstructured stretch of amino acids rich in
prolines to H1 of the actin binding region [33]. This longer
Eps8(535–821) construct displays the same thermodynamic
parameter of association to barbed ends and the sides of actin
filaments as the shorter Eps8(648–821) [17]. Furthermore, the
SH3 domain of Eps8 does not bind actin [17]. These features
allowed us to use this extra mass as a visual marker for the H1
helix without affecting the mode of Eps8 binding to actin. Similar
approaches were employed to localize structural elements in
helical reconstructions of kinesin bound to microtubules using an
SH3 domain as a marker [36] and in Arp2/3 mediated actin
branches using GFP as a marker [37].
In the raw images extra density associated to Eps8 is clearly
visible (red arrowheads in Figure 5B). The corresponding 3D
reconstructions show a significant change in twist (2.16 subunits
per turn) if compared to that of F-actin alone (2.14 subunits per
turn), indicating that Eps8 interferes with intra-filament contacts.
Difference mapping between the reconstruction and control F-
actin (after correcting for the difference in twist) resulted in an
elongated density corresponding to the bound Eps8 (Figure 5B–
5C). Part of the density is located between three actin subunits
making the majority of its contacts with two short-pitch neighbors.
One actin subunit is contacted at the back of subdomains 1 and 2
(grey subunit) and one mostly at the back of subdomain 3 (blue
subunit). The barbed-end, long-pitch neighbor (yellow) of the
latter subunit provides contacts at the top of subdomain 4. The
volume and shape of this density segment corresponds well to the
compact H2–H5 domain of Eps8 (Figure 5C).
A second density segment is located at the hydrophobic pocket
between subdomains 1 and 3 of the blue subunit, consistent with
the biochemical studies placing H1 at this location. This density
segment cannot accommodate the size of the H2–H5 domain. The
remaining density of the second segment, after accounting for the
H1 helix, accommodates the flexibly attached SH3 domain
serving as a visual marker for the H1 position (arrowhead in
Figure 5C). The H1–H2 linker can easily accommodate the
distance between the two density segments if threaded into the
connecting density (Figure 5B–5D). The resulting model brings the
residues that we identified in the cross-linking experiments into
reasonably close apposition to account for the cross-linking
between Eps8 and actin (cyan and yellow circles in Figure 5D).
Eps8 Capping and Bundling Activities Can Be Dissected
In Vitro and In Vivo
The structural model of the interaction of Eps8 with actin
provides the molecular framework to account for both capping
and bundling activities, further suggesting that they can be
dissected. The model predicts that residues involved in accom-
modating the amphipathic, H1 helix into the hydrophobic barbed
end pocket would be critical for capping, and may instead be
dispensable for Eps8 to bind and bundle actin filaments.
Figure 3. Eps8(648–821), Thymosin b4, Ciboulot, and ADF/Cofilin share common binding surfaces on actin. (A–C) Eps8(648–821)
competes with Thymosin b4 and Ciboulot for binding to monomeric actin. The change in fluorescence of 1.5 mM NBD-labeled-actin was measured in the
presence of the indicated, increasing concentrations of Eps8(648–821) and/or saturating amounts (25 mM) of either Thymosin b4 (A) or Ciboulot (B),
or ADF/Cofilin (C) in low salt buffer (G-buffer). In the case of ADF/Cofilin (C), NBD-ADP-actin was used. (D, E) H1–H2 but not H5 compete with Ciboulot
for actin binding. The change in fluorescence of 1.5 mM NBD-labeled-actin was measured in the presence of the indicated, increasing concentrations
of Eps8 helices (H1–H2, left or H5, right) alone or together with saturating amounts (25 mM) of Ciboulot, in low salt buffer (G-buffer). (F) H5 and H1–H2
do not compete for binding to monomeric actin. Change in fluorescence of NBD-labeled-actin in the presence of increasing concentrations of Eps8
helices (H1–H2) alone or together with saturating amounts (25 mM) of Eps8(H5) in low salt buffer (G-buffer). (G) Kinetic constants of dissociation of
various fragments of Eps8 alone or in combination with the indicated actin binding proteins in low salt buffer (G-buffer) (see also Figure S2A–S2B for
competition of Eps8(648–821) and H1–H2 with Thymosin b4 in high salt buffer). The Kds are calculated by fitting the data in (A–F) using Equation 1.
(H) Helical wheel analysis of the predicted helix H1 of EPS8. Alignment of mouse Eps8 H1 helix with the WH2 domains of either human Thymosin b4 and
Drosophila Ciboulot is shown on top left. Helical wheel analysis of the amphipathic helices of mEps8, hThymosin b4, and DCiboulot. The helix is
projected along its axis going into the page. The hydrophilic residues are presented as circles, hydrophobic residues as diamonds, potentially
negatively charged as triangles, and potentially positively charged as pentagons. Hydrophobicity is color coded as well: the most hydrophobic
residue is green, and the amount of green is decreasing proportionally to the hydrophobicity, with zero hydrophobicity coded as yellow. Hydrophilic
residues are coded blue with the potentially charged residues in light blue.
doi:10.1371/journal.pbio.1000387.g003
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most extensive contact with respect to three consecutive actin
subunits within a filament, is likely essential for binding and
bundling filament, but not for capping.
We set out to test these predictions by generating point
mutations. The unique mode of Eps8 wrapped around the
protomeric subunits of actin filaments suggests that mutation in
single key residues in the loop of the extending arm, which is in
close contact to actin units (Figure 5B–5D), should reduce binding
to barbed ends, monomeric actin, and presumably also to the side
of actin filaments. Consistently, mutations of R706A and F708A in
the linker region reduced the affinity for barbed end (Figure 6A,
KcapEps8-WT=7 nM; KcapEps8-Linker mutant =180 nM)
and binding to G-actin (Figure 6A) by around 10-fold with respect
to the WT Eps8(648–821) fragment. These mutations also
significantly reduced side binding (not show) and bundling of
filaments (Figure 6A, right panels), consistent with a role of the
linker in stabilizing the association of Eps8(648–821) to actin
filament. Next, we engineered a second set of mutations in the
amphipathic H1, which is engaged in hydrophobic contacts with
the cleft between subdomain 1 and 3 of actin barbed ends, by
changing non-polar residues of H1 into polar ones. Remarkably,
mutations of two hydrophobic residues into Aspartate (V689D and
L693D) virtually abrogated barbed end binding (Figure 6B,
KcapEps8–WT=6.5 nM, KcapEps8Dcap =700 nM), while leav-
ing side binding and bundling properties unaffected (Figure 6B,
right panels). We obtained similar results when a construct
encompassing the linker, L1, and the four remaining alpha helices,
but devoid of H1, Eps8(701–821) was employed ([17] and Figure
S3B). Thus, collectively these results demonstrate the absolute
requirement of the linker and H1 helix for capping.
We next inspected the sequence encompassing the globular,
helical fold (H2–H5). We found a stretch of amino acids, LNKDE
(757–761), that shares similarities with a motif, which was
identified as critical for mediating the binding and bundling of
actin filament of a variety of actin-binding proteins [38,39], and
displays homology with the Villin head-piece domain, which
contacts the side of actin filaments (herein referred to as Villin-like
motif; Figure 3C) [40]. Within this motif, the key residues, essential
for mediating the interaction between these proteins and actin, are
conserved also in Eps8 (LNKDE), predicting that they may be
important for Eps8 side-binding and bundling activities. It was
shown previously that full-length Eps8 has bundling activity in vivo
[21], presumably due to its ability to dimerize [41,42]. To mimic
the oligomeric state of Eps8, we used Eps8(648–821) wild type and
mutants fused to dimeric GST. Hydrodynamic analysis performed
by size-exclusion chromatography and glycerol gradient sedimen-
tation revealed that the purified GST-Eps8 fragments do not
unspecifically aggregate but form, as expected, dimers driven by
the GST moiety (Figure S4). Co-sedimentation assays showed that
Eps8(648–821) does not support bundling activity by itself but a
GST-tagged construct does (Figure S5 and see also Discussion).
More importantly, a mutant L757A-K759A fused to GST
retained close to GST-WT barbed end binding (Figure 6C,
KcapEps8-WT =4 nM, KcapEps8Dbund =20 nM) but was
completely unable to promote bundling of filaments, even when
used in the high micromolar range of concentrations (Figure 6C,
right panels). Finally, a double GST-fused H1 and Villin-like motif
mutant (DcapDbund) lost both barbed ends binding and bundling
activities (Figure 6D, KcapEps8-WT =16 nM; KcapEps8DcapD-
bund =4mM). We obtained similar results when the ability of the
various GST-Eps8 mutants to form actin bundles was directly
visualized by immunofluorescence staining with phalloidin (Figure
S6). Thus, collectively these data indicate that the capping activity
is primarily mediated by the amphipathic H1 helix, while the
globular H2–H5 core is responsible for bundling. These
biochemical distinct functions are reflected by the ability of Eps8
to support in vitro reconstituted actin-based motility of N-WASP-
functionalized beads [3]. Actin-based motility can, indeed, be
reconstituted in the presence of a minimal set of purified proteins
that includes the ARP2/3 complex, Profilin, Cofilin, and Capping
Proteins [3]. Accordingly, motility of N-WASP-coated beads was
supported by the addition of WT Eps8(648–821) or the bundling
defective mutant (Eps8-Dbund) or the minimal capping region
H1–H2, but not by the capping deficient Eps8-Dcap or the H2–H5
fragment (Figure 7 and Videos S1–S8) fused to GST, even if added
at micromolar concentrations. Consistently, in vivo analysis
indicated that Eps8-Dcap, but neither Eps8-Dbund, which localized
on rocketing tails similarly to WT, nor Eps8-DcapDbund mutant
(Figure S7) was no longer able to fully restore the velocity of
phosphatidylinositol 4,5-bisphosphate (PIP2)-rich rocketing endo-
membranes, whose optimal motility depends on Eps8 (SI Figure 7
and Videos S9–S13) [17]. Additionally, both in spreading mouse
embryo fibroblasts and in migratory B16-F1 mouse melanoma
cells, Eps8-Dcap no longer localized to lamellipodia leading edges
but was present throughout the lamellipodial network and
enriched in microspikes, which are bundles embedded in
lamellipodia that can serve as filopodia precursors (Figure S8).
In contrast, bundling-deficient Eps8 was restricted to the
lamellipodial edge. Thus, there is a tight correlation between the
capping and bundling activities of Eps8 with architectural and
dynamically diverse cellular structures: lamellipodia, which are
sites of high actin turnover made of short filaments with numerous
barbed ends oriented toward the plasma membrane, versus
microspikes/filopodia, which are composed of cross-linked linear,
long actin filament bundles.
Next we set out to identify biological processes that might be
dependent upon a functional bundling rather than capping activity
of Eps8. The residues mutated in the mammalian Eps8 to dissect
the capping and the bundling activities in vitro are conserved
between mouse and nematodes (Figure S9A). Additionally, in C.
elegans, deletion of the eps-8 gene leads to altered microvillar and
intestinal morphology and intestinal dysfunction, which in turn are
responsible for larval lethality [16]. In the nematode there are two
Figure 4. Mapping of the interaction surfaces between Eps8(648–821) and monomeric G-actin by cross-linking coupled to mass
spectrometry. (A) Cross-linking of Eps8(648–821) and actin. Eps8(648–821) and actin, either alone or in combination, were incubated in the absence
(2) or presence (+) of BS2-GD4 (Bis(sulfosuccinimidyl02,2,4,4-glutarate-d4), as a cross-linker, for 45 min. The reaction products were separated by
SDS-PAGE and detected by Coomassie blue staining (shown in grayscale). Two cross-linked protein bands, indicated as 1 and 2, were specifically
detected only when actin and Eps8(648–821) were concomitantly incubated with the cross-linker. (B–C) Identification of Eps8(648–821)-Actin chimaeric
peptides by mass spectrometry. Eps8(648–821) and G-actin were incubated in the absence (2) or presence (+) of the cross-linking agent, as described
above. The two indicated cross-linked species were subjected to mass spectrometry analysis. Right: Table summarizing the sequences of peptides
derived from mass spectrometry analysis of gel band 1 and 2 of the Eps8(648–821):G-actin complex or of Eps8(648–821), containing cross-linked
lysines (K). Numbers on the left indicate the number of times the peptide was found in a typical mass spectrometry analysis. (C) The positions of
BS2G-d0-cross-linked Lysine residues of the peptides identified by mass spectrometry on actin are indicated in red and circled. The corresponding
cross-linked Lysines of H1 and H2 helices of Eps8(648–821) are indicated at the bottom. Actin subdomains (1–4) are also indicated.
doi:10.1371/journal.pbio.1000387.g004
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that lacks the C-terminal region of the protein where the
determinants responsible for interaction with actin are contained.
Only the intestinal expression of EPS-8A could rescue both the
lethal phenotype and the microvillar defect, whereas the EPS-8B
isoform was unable to do so [16], indicating that the intestinal
function of Eps8 is mediated by its C-terminal region and, more
importantly, allowing the use of the worm as a suitable simplified
model to dissect the molecular functions of Eps8.
We engineered mutants of the nematode eps-8 gene putatively
lacking either the capping (EPS-8ADcap) or the bundling (EPS-
8ADbund) functions. We could confirm that the mutants fused to
GST were selectively impaired in their actin barbed end capping
and actin bundling activities, respectively (Figure 8A–8B). A
mutant harboring both types of mutations (EPS-8ADcapDbund)
displayed severe reduction of both capping and bundling activities
(Figure 8C).
Next, we generated heterozygous eps-8 transgenic lines express-
ing either EPS-8A-WT or EPS-8 genes harboring the two
mutations (alone or in combination). The mutant proteins
localized on the lumina, apical side of the intestine, indistinguish-
ably from the WT protein as judged by morphological analysis
and localization with respect to DLG-1::RFP transgene, that
encodes for the apical junctional marker Discs, large homolog-1
Figure 5. Modeling and electron microscopy of Eps8 assemblies. (A) Ribbon diagrams of the resolved, NMR, tertiary structure of the C-terminal
region of human Eps8 (aa 699–784) (PDB ID: 2E8M), human Eps8L2 (aa 612–697) (PDB ID: 1WWU) and of the predicted tertiary structure of the C-terminal
region of murine Eps8(703–794) obtained by Phyre software. Please note that in the NMR structures of human Eps8 (PDB ID: 2E8M) and Eps8L2 (PDB ID
1WWU) the linker, L1, appears in a disorder state suggesting that it is not part of the compact globular core (not shown). (B) Three-dimensional
reconstruction of Eps8(535–821) bound to actin filaments. A reconstruction of undecorated actin filaments is shown for reference on the left, and the
reconstruction of actin filaments with bound Eps8 is shown on the right. The four actin subdomains are marked on the actin filament reconstruction.
The difference map corresponding to actin-bound Eps8(648–821) is highlighted in red. For clarity, we mapped the difference only on one of the actin
subunits. Representative images of undecorated actin (left) and actin decorated with Eps8(648–821) (right) are also shown. Some of the more obvious
attached Eps8(648–821) particles are marked by red arrowheads. (C) Difference map generated by subtracting the undecorated actin filament
reconstruction from the reconstruction of the Eps8(535–821) bound to actin filaments (grey transparent surface). For clarity, only one asymmetric unit
along the filament is shown. Two views, related by a 60u counterclockwise rotation around the filament axis, are shown. The pointed end is to the top
of the figure. Three actin subunits (blue, yellow, and light grey surfaces) are shown for reference. Subdomains 1–4 are labeled on the actin subunits.
The difference density partitions into two main regions. At lower contour levels, these parts are connected by a bridge of density. The docked model
of Eps8(648–821) is shown in red cartoon representation. There is some extra density (arrow head) close to H1 representing the flexibly attached SH3
domain. (D) Modeled complex between one actin monomer in the filament (blue) and Eps8(648–821) (red) in cartoon representation. Residues K330 on
actin and K707 on Eps8 are marked with cyan circles. Residue K375 of actin is marked by a yellow circle. Please note that the red density in Figure 5B
and the transparent density 5C show the same density only in different representations. The Eps8(535–821):actin stoichiometry in the reconstruction
is by 1:1 with each Eps8(535–821) contacting three actin protomers along the filament.
doi:10.1371/journal.pbio.1000387.g005
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analyzed the survival of the progeny of heterozygous eps-8 mutants
expressing the different arrays. Lethality of the F1 eps-8
homozygous worms was rescued by the EPS-8ADcap mutant
but not by EPS-8ADbund or EPS-8ADcapDbund ones (Figure 8E).
Thus, the bundling but not the capping activity of EPS-8 is
responsible for the proper intestinal morphology, reflecting
its requirement in the architectural organization of actin in this
tissue.
Discussion
Here, we have defined the molecular basis through which Eps8
binds to the sides and caps actin filaments (Figure 9). Electron
microscopy, biochemical, cellular, and mutagenesis studies indicate
how distinct portions within the C-terminal region of Eps8
contribute to bind actin. The first region, H1, is crucial for capping,
whereas the second region, composed of four alpha helices
organized into a globular core (H2–H5), is crucial for bundling.
This latter region is connected to H1 via a linker segment. The
relatively weak interactions of the H2–H5 globular core and the
linker with the actin filament are primarily responsible for the side
binding of Eps8 (Figure 9B) while H1 only contributes little to side
binding. The flexibility of the linker allows the amphipathic helix
H1 to plug into actin’s hydrophobic binding pocket at barbed ends,
acting as a lock that increases the binding affinity of Eps8 actin
binding domain from 10
6 to 10
9 M
21, as typically observed for
cappers (Figure 9C) [44,45]. CP, for instance, adopts a similar
mechanism whereby full capping activity is achieved when a flexible
domain swings into the hydrophobic pocket, locking barbed ends
[13]. Thus, the capping activity of Eps8 appears to be determined
by a clamp mechanism by which the extended C-terminal Eps8
domain fasten around the barbed end actin unit blocking further
filament elongation (Figure 9C). Within this context, both the side
binding of the globular core and the end binding mediated by H1
are spatially coordinated by the linker and contribute to the high
affinity interaction of Eps8 to filaments ends (accounting also for the
slightly reduced affinity for barbed ends of the bundling-deficient
mutants). The flexibility of the linker ensures also a bimodal
topological arrangement of Eps8 with respect to either the side or
the barbed end of the filaments, reflecting its bundling or capping
activities,respectively.Thesetwo latterfunctionsofEps8canindeed
be dissected and consistently exert distinct roles in diverse actin-
based processes.
The Actin Capping Activity of Eps8 Requires the
Amphipathic H1 Helix
Various lines of evidence support the notion that the H1 actin-
binding surface of Eps8 is critical for capping, displaying a binding
mode similar to WH2 domain: (i) Competition binding studies
show that an Eps8 fragment encompassing the entire five terminal
a-helices (Eps8 648–821) or the isolated H1–H2, but not H5, can
displace the WH2 domain-containing proteins Ciboulot, Thymo-
sin b4, and ADF/Cofilin from actin. Binding of these proteins to
the hydrophobic pocket between subdomain 1 and 3 of actin is
well established [27,46]. (ii) Mass spectrometry identification of
chemically cross-linked peptides of the Eps8:actin complex
revealed that K675 and K683 on H1 are in close proximity to
K375, a residue of actin in the hydrophobic cleft on subdomain 1.
(iii) Helical wheel analysis showed that H1 forms an amphipathic
helix which displays the same ‘‘signature’’ of conserved hydro-
phobic residues as the helix of the WH2 domain [47]. (iv)
Mutations of the hydrophobic residues in the amphipathic helix
H1 cause a significantly reduced capping activity in vitro.
Engineered mutants of the nematode EPS-8 gene lacking H1 also
show impaired capping activity. In addition, mutated Eps8 fails to
support actin-based motility and to restore PI4,5K-induced vesicle
motility when expressed in Eps8 null mouse embryo fibroblasts.
Many actin-binding proteins, including DBP (Vitamin D
binding protein), Gelsolin, ADF, the WH2 domain of Ciboulot,
VASP, WASP, and WAVE2 [46,48], share similar modes of
binding. Notably, they all contact the hydrophobic cleft between
subdomains 1 and 3 of actin. Although the morphology of the cleft
is likely to change upon filament formation, it is accessible to some
extent in both G and F forms of actin. For example, thymosin b4
binds tightly to the hydrophobic cleft of monomeric actin,
sequestering G-actin up to a certain concentration threshold. At
higher concentrations, it becomes incorporated into filaments [49].
Structural studies showed that thymosin b4 binding to F-actin
interferes with intra-filament contacts and changes the twist of
actin from 2.16 subunits per turn to 2.14 subunits per turn [50].
We show here that Eps8 can bind G-actin as well as F-actin.
Interestingly, Eps8 binding also changes the actin filament twist to
2.14 subunits per turn, indicating that it interferes with intra-
filament contacts in a similar fashion as thymosin b4.
One of the functions of WH2 domain, such as in the case of
Ciboulot, WASP, and N-WASP, is to participate in barbed end
assembly [47,51,52]. This, however, is not the case for Eps8,
which instead tightly caps actin filament barbed ends. This
Figure 6. Eps8 capping and bundling activities can be dissected. (A) The barbed end capping and bundling activity of Eps8 requires an intact
H1-to-H2 Linker (Linker mutant) region. Left: the position of critical, mutated residues of the H1-to-H2 Linker in the modeled complex Eps8(648–821):G-
actin are indicated by a star. Middle: the rates of elongation from barbed ends using spectrin-actin seeds and 2 mM of G-actin (10% pyrenyl-labeled) in
the presence of increasing concentrations Eps8(648–821)-R706A-F708A-(Eps8-Linker mutant) (orange line) with respect to Eps8(648–821)(Eps8-WT)
(gray lines) are shown. Rates are normalized taking as 100% the rate of elongation from barbed ends measured in the absence of Eps8-WT. Symbols
indicate data; line indicates fitted binding curves for a complex with 1:1 stoichiometry. The curve is calculated using Equation 1. The kinetic constants
(Kcap) of barbed end inhibition for Eps8-Linker mutant =180 nM; Eps8-WT =9 nM. Right: the F-actin bundling ability GST-fused Eps8-WT or Eps8-
Linker mutant was determined by co-sedimentation assays. F-actin (1 mM) was incubated either alone or in the presence of the indicated
concentrations of GST, as control, or GST-fused WT or mutated Eps8(648–821). The mix was subjected to centrifugation at 10,000 g for 30 min.
Aliquots of the pellet (P) and supernatants (S) were analyzed by immunoblotting with the antibodies indicated on the right. (B) The barbed end
capping but not the bundling activity of Eps8 requires an intact H1 amphipathic helix. Left: the position of critical, mutated residues of the H1 in the
modeled complex Eps8(648–821):G-actin are indicated by a star. Middle: the rates of elongation from barbed ends using spectrin-actin seeds in the
presence of increasing concentrations of Eps8-WT (gray lines) or Eps8(648–821)-V689D -L693D (Eps8-Dcap) (orange line) are shown. The Kcap of the
Eps8-Dcap =700 nM. Right: the F-actin bundling ability of the indicated Eps8-Dcap was determined as described in (A). (C) The bundling, but not the
capping, activity of Eps8(648–821) is mediated by a Villin-like motif in the globular, helical domain. Left: the critical, mutated residues in the Villin-like
motif of Eps8(648–821) are indicated in red, and their position in the modeled complex Eps8(648–821):G-actin is indicated by a star. Middle: the rates
of elongation from barbed ends in the presence of increasing concentrations of Eps8(648–821)-L757A-K759A (Eps8-Dbund) (orange line) with respect
to Eps8-WT (gray line), obtained as described in 6A, are shown (Kcap of Eps8-Dbund =20 nM). Right: the F-actin bundling ability of GST-Eps8-Dbund
was determined as in 6A. (D) Actin capping (middle) and bundling (right) of Eps8(648–821) are impaired by a mutation in the helix H1 and in the Villin-like
motif (Eps8-DcapDbund), whose position within the complex Eps8(648–821):G-actin is shown on the left.
doi:10.1371/journal.pbio.1000387.g006
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domain of Ciboulot can only bind ATP-actin, in a ‘‘profilin-like’’
mode, whereby detachment of the WH2 domain from the last
subunit of a filament takes place following ATP hydrolysis.
Conversely, the Eps8 actin-binding region binds both ATP- and
ADP-actin, with equivalent affinities. This property may provide a
mechanism by which Eps8, upon binding to the barbed end actin
via H1, does not dissociate after ATP hydrolysis. This mechanism
would allow Eps8 to remain clamped to filaments ends, blocking
further actin assembly.
The Globular H2–H5 Helical Lobe Is Responsible for Eps8
Bundling In Vitro and In Vivo
The globular lobe, composed of H2–H5, is primarily respon-
sible for the bundling activity of Eps8 as indicated by the findings
that: (i) the isolated H2–H5 domain of Eps8 is sufficient to bind
and bundle filamentous actin [20,21]; (ii) mutations in key
conserved residues (from mammalian organisms to C. elegans)
within this domain (see below) abolished F-actin binding and
bundling, while leaving unaffected the ability of the domain to cap
actin filaments. In the 3D reconstruction the H2–H5 lobe, which
displays no obvious sequence homology with other actin cross-
linkers, is located in between three actin subunits of the filament
with the major contacts at subdomain 3 of the actin subunit that
has H1 bound and with subdomain 4 of the actin subunit below.
This is significantly different from other F-actin bundling proteins,
such as Fimbrin and Vinculin, which share common actin
interacting surfaces, associating along the filament between
subdomains 1 and 2 of two adjacent actin protomers [53–57].
Conversely, the helical lobe of Eps8 binds actin filament mainly
through a critical stretch of amino acids (LNKDE), which
resembles those identified in the headpiece of Villin (LKKEK)
[38] and in a variety of other actin-binding proteins homologous
to villin headpiece [39]. Interestingly, EM reconstructions show
villin headpiece as well as dematin headpiece binding in a similar
location on F-actin as the H2–H5 lobe of Eps8 [58].
As for the mechanism of Eps8 bundling, it is generally accepted
that a protein can bundle actin by cross-linking adjacent filaments
through two distinct binding surfaces or through dimerization
when it possesses a single F-actin binding site. Alternatively, since
actin filaments are poly-electrolytes, proteins rich in basic residues
(such as small molecules or proteins like calponin, EF1alpha,
MARCKS, the monomeric C-terminal domain of cortexillin
[59,60]) can, by associating to the sides of actin filaments,
neutralize the repulsive charges of the actin polymer driving
bundling [61]. In the case of Eps8, this latter possibility is unlikely
since the minimal, isolated actin binding region, 648–821 (cleaved
from the GST moiety) displays little if no bundling activity (Figure
S5). Conversely, both GST-tagged Eps8(648–821) and full-length
Eps8, in the absence of GST tag, can dimerize in vitro and in vivo
[40,41] and possesses bundling activity in vitro [21]. Furthermore,
this latter activity is significantly enhanced by association of Eps8
with IRSp53 [21], whose ability to dimerize through its IMD
domain has been documented both by in vitro structural studies
and in vivo experiments [62–64]. Thus, we propose that Eps8
cross-links actin filaments by forming homo- or hetero-dimers (in
this latter case, with IRSp53).
Correlating Dual Role of Eps8 Modes of Actin-Binding
from In Vitro to In Vivo
Here we have provided evidence that two segregated actin
binding domains confer Eps8 with bimodal functionality: capping
and bundling. We had previously shown that this duality is
regulated in the context of the full-length protein by activation of
different effectors (IRSp53 and ABI1 [20,21]). Our data support
the notion that this bimodal functionality in the context of one
single protein can be dissected and exert independent, cell- and
tissue-specific roles.
The bundling but not the capping function of Eps8 is
presumably essential for the proper structural organization of
gut microvilli, which are composed of parallel, highly cross-linked
actin filaments [65]. Importantly, the role of Eps8 in the intestine
is conserved also in mice, where Eps8 genetic removal disrupts
intestinal morphology leading to reduced fat absorption, calorie
restriction, and improved metabolic status [66]. Filament side
binding and bundling of Eps8 are also critical to direct the protein
to microspikes. This is consistent with the role of Eps8 (together
with IRSp53 [21]) in filopodia formation and also suggests that
Eps8 through its cross-linking properties may be generally
implicated in the regulation of highly dynamic structures
composed of parallel actin bundles.
The capping activity instead is required to reconstitute actin-
based rocketing motility in vitro and for optimal velocity of
intracellular pathogens [17] or PIP2-rich endomembranes in vivo;
to restrict localization of Eps8 to the leading edge of the cell in
migratory cells; and to control the number of axonal filopodia in
primary hippocampal neurons [30]. In these latter cells, Eps8 acts,
like capping proteins CP [67], by negatively regulating, through
barbed end binding, the filament lengths of the actin networks
from which filopodia then arise.
Finally, the role of Eps8 as a bifunctional actin remodeller
further suggests that this protein by controlling various actin-based
protrusions regulates optimal cell locomotion both in physiological
and in pathological contexts, such as during tumor development.
In keeping with this latter possibility, Eps8 has been reported to be
unregulated in a variety of tumor types and to be specifically
required for optimal cell migration and invasion in a subset of
metastatic oral squamous carcinoma cells [68,69]. Whether the
capping or bundling activities are critical for Eps8 to exert this pro-
invasive functions remains to be tested. However, the availability
of Eps8 mutants specifically impaired in either one of its actin-
related functions will be instrumental in addressing this issue and
certainly worthy to be investigated.
Materials and Methods
Proteins and Reagents
Actin was purified from rabbit muscle acetone powder from Pel-
freez, isolated as CaATP-G-actin by Superdex 200 chromatogra-
phy in G-buffer (5 mM Tris-Cl, pH 7.8, 0.2 mM ATP, 1 mM
DTT, 0.1 mM CaCl2). Actin was pyrenyl labeled on C374 and
NDB labeled on K373. The various Eps8 fragments and single
point mutants were cloned in the expression vector pGEX6P1,
induced at 22uC with 0.5 mM IPTG overnight and purified as
described previously [17]. The protein Thymosin b4, Ciboulot,
Figure 7. The EPS8 capping but not its bundling activity is required to reconstitute actin-based motility in biomimetic motility
assays. N-WASP coated beads (2 mM) were mixed with a biomimetic motility medium in the absence of any capping protein or in the presence of
50 nM of Gelsolin, or 150 nM of GST-fused EPS8(648–821), or 500 mM of EPS8-Dbund mutant, or 10 mM of EPS8-Dcap mutant, or 10 mM of EPS8-
DcapDbund mutant or 2 mMH 1 –H2 or 10 mMH 2 –H5 fragments. Reactions were incubated for 30–60 min before starting imaging recording. Images
taken at the indicated time points from supplemental videos (Video S1–S8) are shown. Bars, 5 mm.
doi:10.1371/journal.pbio.1000387.g007
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PLoS Biology | www.plosbiology.org 15 June 2010 | Volume 8 | Issue 6 | e1000387Figure 8. Analysis of actin-binding mutants of nematode EPS-8A (Ce-EPS-8A). (A–C) The barbed end capping (left) and F-actin bundling
(right) activities of the indicated mutants fused to GST (A, Dcap; B, Dbund; C, DcapDbund) are shown. The mutants were engineered in the context of
a C-terminal fragment of Ce-EPS-8A (aa 714–917, WT in all panels) that recapitulates the actin binding properties of full-length Ce-EPS-8A. Left panels:
rates of elongation from plus ends using spectrin-actin seeds and 2 mM of G-actin (10% pyrenyl-labeled) in the presence of increasing concentrations
of the indicated constructs. Rates are normalized taking as 100% the rate of elongation from barbed ends measured in the absence of Ce-EPS-8A-WT.
Binding curves were fitted for a complex with 1:1 stoichiometry as described in Materials and Methods. The kinetic constants (Kcap) of barbed end
inhibition were: WT, 108 nM; Dcap, 980 nM; Dbund, 205 nM; DcapDbund, .4,000 nM. Right panels: the F-actin bundling ability of the indicated
constructs was determined by co-sedimentation assays. F-actin (1 mM) was incubated either alone or in the presence of the indicated constructs. The
mix was subjected to low-speed centrifugation for 1 h. Aliquots of the pellet (P) and supernatants (S) were analyzed by IB, as shown. (D)
Photomicrographs depicting intestinal morphology of wild-type (WT), eps-8(by160), and eps-8(by160) expressing EPS-8 WT or mutant proteins (Dcap,
Dbund, and DcapDbund) under a gut specific promoter. Fusion of the EPS-8 constructs to GFP allowed their visualization in epifluorescence. Merges of
Normaski and epifluoresence photomicrographs are shown (proteins are in green) (see also Figure S8B). To facilitate visualization of the gut
phenotype, cartoon panels are depicted underneath each merged image. The intestinal lumen is also indicated. Bar, 10 mm. Worms are oriented with
the head pointing down or to the left. (E) Summary of the rescue of lethality and intestinal morphogentic defects by the expression of CeEPS-8 mutants.
1Rescue of lethality was tested in two different transgenic lines for each construct. At least 100 GFP positive L1 larvae (F1), from heterozygous eps-8
animals (F0), were individually plated and allowed to grow and self-fertilize. Rescued homozygous eps-8 mutants were recognized by loss of the
genetic balancing markers (unc-26, dpy-4) and positivity for GFP expression. Confirmation for homozygosity for the mutated eps-8 allele was obtained
by PCR [16]. Alternatively, the entire progeny (ranging from 30 to 120 F1 animals) of at least three heterozygous adults was individually plated and
allowed to grow and self-fertilize. Rescue of lethality analysis was performed as described above.
2Intestinal alterations in homozygous eps-8(by160)
mutant worms are characterized by constipation and/or paleness, with the presence of clumped and more refractile gut granules (see Figure 8D).
Rescue of this phenotype was scored in live L1/L2 larvae under a microscope with Nomarski optics and epifluorescence. For the analysis of the gut
phenotype in eps-8(by160) opt-2:EPS-8ADbund and eps-8(by160) opt-2:EPS-8A-DbundDcap, homozygous larvae were identified by growth retardation
respective to siblings in a synchronous F1 progeny from heterozygous worms. The percentage of worms displaying intestinal defects is shown. In
parentheses, the number of analyzed animals is reported.
doi:10.1371/journal.pbio.1000387.g008
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as described before [70]. Eps8 point mutants were generated by
PCR and sequenced verified.
Actin Polymerization Measurements
Initial rates of filament growth from the barbed end and the
pointed ends were measured spectrofluorometrically using either
spectrin-actin seeds or phalloidin-actin seeds and gelsolin-actin
seeds as previously described [29]. Gelsolin-actin seeds were
prepared by adding gelsolin and 2.5 molar equivalent Ca ATP-G-
actin in G-buffer. Phalloidin-actin was prepared by adding four
molar excess of phalloidin to F-actin and vigorous mixing. The
concentration of seeds was determined by measuring the initial
rate of increasing amounts of seeds in the presence of 2 mMG -
actin (10% pyrenyl-labeled). The concentration of seeds was
determined using the following rate of elongation equation: V =
[seeds] 6k+ 6(C-Cc) with k+ =10mM
21 s
21.
Nucleotide Exchange on G-Actin
Kinetics of nucleotide exchange on monomeric actin was
monitored using the change of fluorescence of eATP upon binding
to G-actin and analyzed as previously described [29].
Equilibrium and Kinetic Measurements of the Interaction
of Eps8(648–821), H1–H2, or H5 with G-Actin
The change in fluorescence of NBD- or AEDANS-labeled actin
was used as a probe for the formation of complexes of G-actin with
Eps8(648–821), H1–H2, or H5. Static fluorescence measurements
were carried out on a LS55 fluorescence spectrometer from Perkin
Elmer. Excitation and emission wavelengths were 475 nm and
530 nm for NBD-actin and 340 and 460 nm for AEDANS actin,
respectively. The amount of complex was determined by setting at
100% the change of fluorescence measured in the presence of
saturating amounts of Eps8(648–821), H1–H2, or H5. The
equilibrium dissociation constant for the complex was derived
Figure 9. A schematic model for the binding modes of Eps8 to actin. (A) A cartoon representation of Eps8 actin binding region and
monomeric actin. The N-terminal amphipathic helix, H1, the connecting linker, L1, and the globular helical core, H2–H5, of Eps8 actin binding region
are indicated. Monomeric actin is oriented with its barbed end downwards. Actin subdomains are numbered from 1 to 4. (B) Binding of Eps8 C-
terminal region to the side of actin filament is mainly mediated by the globular helical bundle (H2–H5). The helical bundle (H2–H5) positions in the
long grove of the filament, contacting three actin subunits. The amphipathic helix (H1) does not contribute significantly. The H1 binding site may not
be fully exposed in filamentous actin. (C) At the barbed ends, the H1 binding site is fully accessible and H1 can bind within the hydrophobic pocket
blocking further addition of monomeric actin. (D) A similar arrangement as seen at the barbed end is presumably occurring on monomeric actin,
accounting for the sequestering activity of Eps8. In (B–D), two views, related by a 60u counterclockwise rotation around the filament axis, are
shown.
doi:10.1371/journal.pbio.1000387.g009
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of the complex with respect to the total concentration of
Eps8(648–821), H1–H2, or H5 using Equation 1.
Equation 1:
EA ½  ~ 1=2 ðÞ AO ½  z EO ½  zKcz AO ½  z EO ½  zKc ðÞ
2{4A O ½  : EO ½ 
   n 1=2
AO ½  , the total concentration of actin:
EO ½  , the total concentration of Eps8 684{821 ðÞ , H1{H2, or H5:
Actin Cross-Linking Assays
Cross-linking of actin filaments induced by Eps8 mutants and
WT was determined by co-sedimentation as described [20,21].
PPDM Cross-Linking of Eps8(648–821) and Actin
G-actin and Eps8(648–821) were solubilized in a buffer
containing 5 mM Hepes pH 7.8, 0.2 mM CaCl2, 0.2 mM ATP
by using a D-Salt Extracellulose Desalting columns (PIERCE). G-
actin and Eps8(648–821) were mixed and incubated for 5 and
10 min with 16 mM of PPDM (N,N’-(1,4-Phenylene)dimaleimide)
(Fluka) at room temperature. Following addition of 10 mM DTT,
samples were resolved by SDS-PAGE.
Biomimetic Motility Assays
Polystyrene carboxylated beads (2 mm in diameter) were coated
with 200 nM N-WASP and placed in a reconstituted motility
medium that consisted of 7 mM F-actin, 10 mM ADF, 2.4 mM
Profilin, 100 nM Arp2/3 complex, and different amounts of
capping protein (gelsolin or GST-Eps8 648–821 wt or mutated).
An aliquot of 5 ml of the mix was placed between a slide (superfrost
plus, Menzel-Glaser, GmbH, coated with SL2 Sigmacot) and a
coverslip and sealed with Valap (vaselin:lanolin:paraffin 1:1:1).
Phase-contrast time-lapse were taken using a CCD camera
(Hamamatsu ORCA II) on an Olympus AX microscope with a
206objective. MetaMorph 5.0 software was used for acquisition.
Beads were incubated for 30 min before starting time lapse
recording. Images were recorded every 30 s for 20 min.
Cross-Linking Reaction, Protein Digestion, and Chemical
Cross-Linked Peptide Purification
The complex between human Eps8(648–821) and actin was
purified by gel filtration and subjected to chemical cross-linking
followed by mass spectrometry analysis as described (see also Text
S1 for additional details) [71].
Electron Microscopy
Rabbit skeletal muscle actin was prepared and stored as
described in Volkmann et al. [72]. Filamentous actin (F-actin)
was used within 2 to 3 wks of preparation. F-actin samples were
diluted to 0.03–0.07 mg/ml just before the application to glow-
discharged 400-mesh copper grids coated with lacey carbon film.
Dilution Buffer (Buffer A): 5 mM NaPi pH 7.0, 20 mM NaCl,
1 mM MgCl2, 0.1 mM EGTA, 2 mM NaN3. All protein samples
(excluding F-actin) were spun at 4uC for 10 min at 15,000 rpm
prior to dilution (Buffer A). Following 30–60 s of incubation in a
humidity chamber, the sample was blotted and stained with 2%
aqueous uranyl acetate. Images were recorded at a dose of
,50 e
2/A ˚ 2 with a Tecnai G2 T12 electron microscope (FEI
Company, Hillsboro, OR) at 120 keV with a nominal magnifica-
tion of 52,000 and 1.5 mm defocus. Images were digitized using a
SCAI scanner (Integraph Corporation, Huntsville, AL) with pixel
size of 0.4 nm on the sample.
Image Processing
For reconstruction of Eps8 C-terminal domain (residues 535–821)
bound to F-actin, we applied a modified version [35] of the iterative
helical real space refinement method [34] to selected filaments that
clearly showed decoration by visual inspection. The first step of the
procedure is the selection of overlapping boxes containing short
helical segments. A box size of 80680 pixels with a 0.54 nm pixel size
was used. This corresponds to about 15 asymmetric units of the helix,
a little over one actin crossover. An overlap of 60 pixels was chosen,
allowing everyasymmetricunit tocontribute tofourdifferentviewsof
the helix. A total of 36,550 units contributed to the average. The twist
of the reconstruction refines to 2.14 subunits per turn, which
corresponds to a rotation of 2168u between symmetry neighbors
along the short-pitch helix. Control reconstructions of F-actin alone
were also calculated resulting in a twist of 2.16 subunits per turn, a
rotation of 2166.66u. After compensating for the difference in twist,
the Eps8-decorated and undecorated F-actin reconstructions were
optimal aligned using the density-fitting module of CoAn [73] and
difference maps were calculated.
Docking and Modeling of Eps8 C-Terminal Domain
Bound to F-Actin
The difference density resulting from subtracting the control F-
actin reconstruction from the Eps8-F-actin reconstruction was used
to dock the atomic model of helices H2–H5 using the statistics-
based density docking method implemented in CoAn (Volkmann
Acta Cryst, 2009) [73,74]. The statistical analysis indicated a
rotational degeneracy along its long axis. The H1 model and its
interactions with actin were taken straight from the ciboulot crystal
structure (1sqk) [27]. H1 could bind in two ways between
subdomains 1 and 3, either with the N-terminal at the front or at
the back of the actin subunit. Both modes of binding have been
observed for different actin binding proteins [32]. The modeled
configuration (N-terminus at the back) is more consistent with the
cross-linking studies presented here. The linker was modeled
directly into the density using PyMOL [75]. Stereo chemistry
constraints to avoid clashes and ensure connectivity were imposed
using REFMAC [76]. Molecular representations were generated
with Chimera [77].
C. Elegans Strains, Constructs, and Rescue Experiments
The C. elegans EPS-8A mutants were generated by introducing
point mutations in either the C-terminal, actin binding region
[CeEPS-8A(aa 714–917)], for actin biochemical assays, or in the
full-length protein, for expression into nematodes. Mutants were
EPS-8A Dcap = L784E, V788E; EPS-8A Dbund = L849A,
K851A; EPS-8A DcapDbund = L784E, V788E, L849A, K851A.
Worms were grown at 20uC on agar plates seeded with
Escherichia coli strain OP50 under standard laboratory conditions.
The wild-type C. elegans was variety Bristol, strain N2. The eps-
8(by160) strain was previously isolated and characterized in our
laboratory [16,17]. cDNAs of the wild-type (WT) EPS-8A or
mutants were cloned under the intestinal opt-2 promoter into
pPD95.75 vector that provides a C-terminal GFP tag (kindly
provided by A. Fire, Stanford University, USA) and sequence
verified. EPS-8 constructs were injected into EPS-8 heterozygous
animals at a concentration of 5–20 ng ml
21, along with ttx-
3p::RFP expressed in the AIY neuron, to trace for successful
injections. The DLG-1::RFP transgene-expressing strain was
kindly provided by Martha Soto (Rutgers University).
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Figure S1 Interaction of Eps8 actin binding domain and
its fragments with NBD actin. (A) Fluorescent spectra of NBD-
actin in the presence or absence of Eps8(648–821). NBD-labeled actin
(1.5 mM) was incubated in the absence (red line) or the presence
(blue line) of 200 nM of Eps8(648–821) for 60 min, before
recording fluorescent spectra between 480 and 600 nm of
wavelength. (B) Sequence comparison and secondary structure predicted
organization of the Eps8 actin binding domain. Multiple sequence
alignment of a collection of the C-terminal region of Eps8 and its
homologues. Protein sequences were aligned using the ClustalW
program. Manual adjustments were introduced on the basis of
secondary structure information, and the picture was produced
using Jalview. Secondary structure prediction was made by using
the prediction server SAM-T99. Additional sequence information
is in the legend to Figure S3. On top, a schematic organization
into the predicted helices of the C-terminal actin binding domain
of Eps8 is shown. Numbers indicate murine aa. (C) Summary of the
binding ability of various helices of Eps8(648–821) to G-Actin. The
change in fluorescence of 1.5 mM NBD-labeled-actin was
measured in the presence of the indicated Eps8 fragments in G-
buffer. A change in fluorescence caused by the formation of the
complex between actin and Eps8 fragments of at least 10% with
respect to actin alone was scored as positive (+). (D) Coomassie
staining of purified H1–H2 and H5. Purified H1–H2 and H5 helices.
Purified H1–H2, actin (left panel), and two different amounts
(micrograms) of H5 (right panels) were resolved on SDS-PAGE
and stained with Coomassie blue (pseudocolored in black). (E)
Fluorescent spectra of NBD-actin in the presence or absence of either H1–H2,
or H5 or Eps8(648–821). Monomeric NBD-labeled actin was
incubated in the absence (red line) or the presence of 20 mMo f
Eps8(648–821) (blue line), or H1–H2 (light blue line) or H5 (violet
line) for 60 min, before recording fluorescent spectra between the
indicated wavelengths.
Found at: doi:10.1371/journal.pbio.1000387.s001 (2.83 MB TIF)
Figure S2 (A) Eps8(648–821) compete with Thymosin b4
for AEDANS actin binding at high salt (F-buffer). The
change in fluorescence of 1.5 mM AEDANS-labeled-actin was
measured in the presence of increasing concentrations of
Thymosin b4 and 0, 15, or 30 mM of EPS8(648–821) in 0.1 M
KCl and 1 mM MgCl2. Under these conditions, the Kd of
Thymosin b4i s3mM, and the Kapp (K apparent) are 9 mM and
14 mM in the presence of 15 mM and 30 mM of Eps8(648–821),
respectively. According to the equation: Kapp =K T
0(1+
[Eps8(648–821)]/KEps8(648–821)) where Kapp is the binding con-
stant of the Thymosin b4 in presence of the indicated
concentration of Eps8(648–821), KT
0 is the binding constant of
the Thymosin b4 in absence of Eps8(648–821) and KEps8(648–821),
the binding constant of Eps8(648–821). We can approximate a Kd
of ,3 mM for Eps8(648–821), at high concentration of salt. (B) The
fragment H1–H2 is sufficient to compete with Thymosin b4 for binding to
monomeric actin. The change in fluorescence of 1.5 mM AEDANS-
labeled-actin was measured at increasing concentrations of
Thymosin b4 and 0, 10, or 15 mMo fH 1 –H2 in presence of
0.1 M KCl and 1 mM MgCl2. In these conditions, the Kd of
Thymosin b4i s3mM, and the Kapp (K apparent) are 6 mM and
11 mM in the presence of 10 mM and 15 mMo fH 1 –H2,
respectively. As described above for Eps8(648–821), we can
approximate a Kd of ,3 mM for H1–H2 at high concentration
of salt. Please note that under the conditions described above, we
could not obtain reliable results using H5 and in the presence or
absence of Thymosin b4 likely due to the low affinity of H5 for
AEDANS-actin. (C) Limited proteolysis of the C-terminal Eps8 fragment.
Eps8(648–821) (0.5 mg/ml) was digested with chymotrypsin (C),
trypsin (T), Elastase (EL), and proteinase K (PK) at the dilution 1/
10,000 I in the buffer (50 mM Tris pH 7.5; 50 mM NaCl; 1 mM
DTT) for the indicated time at room temperature. Digestion was
terminated by the addition of phenylmethylsulfonyl fluoride
(1 mM). Aliquots of the protelytic peptides were resolved by
SDS-PAGE and stained with Coomassie Blue. The proteolytic-
resistant fragments, indicated by boxes, were subjected to N-
terminal sequencing. The resulting amino acid sequence is
reported at the bottom.
Found at: doi:10.1371/journal.pbio.1000387.s002 (0.64 MB TIF)
Figure S3 EPS8(648–821)-R706A-F708A(Eps8-Linker mu-
tant) and an H1-deleted mutant [also indicated as EPS8-
L1-H2-H5(701–821)] display reduced G-actin binding
affinity with respect to WT. (A) The change in fluorescence
of 1.0 mM NBD-labeled-actin was measured in the presence of the
indicated, increasing concentrations of EPS8(648–821)-Linker
mutant. Symbols indicate data; line indicates fitted binding curves
for a complex with 1:1 stoichiometry. The curve is calculated using
Equation 1. (B) The EPS8-L1-H2-H5(701–821) fragment binds G-
actin in a concentration-dependent manner. Left, the change in
fluorescence spectra of 1.5 mM NBD-labeled-actin was measured at
saturating concentrations of EPS8-L1-H2-H5(701–821) fragment
under physiological conditions. Right, EPS8-L1-H2-H5(701–821)-
mediated, dose-dependent changes in fluorescence of NBD-actin.
Symbols indicate data; line indicates fitted binding curves for a
complex with 1:1 stoichiometry. The curve is calculated using
Equation 1. (C) A Villin-like motif is conserved in EPS8 and its
family members. Sequence alignment of a Villin-like motif of Eps8
from various species and of murine Eps8L1 and Eps8L2 with Villin
headpiece domain. The key residues, which have been shown to be
critical for mediating actin binding and bundling of Villin [2] and
Eps8 family members, are highlighted. Abbreviations: Hs, homo
sapien;Mm,MusMusclus;Xl,Xenopousleavis;Ce,Caernorabditis
elegans. It must be pointed out that due to limited similarity
between the C-terminal region of Eps8 and the Villin HeadPiece
domain, a simple comparison of primary sequences does not allow
the identification of additional conserved key residues. However, we
inspected in greater detail the ternary structure of Eps8 C-terminus
and Villin Headpiece and found a number of similarities. More
specifically, the residues R771, R763, and K759 (which is mutated
to A in Eps8Dbund mutant) of Eps8 C-terminus are in a position
structurally equivalent (i.e. they form a positively charged surface
presumably facing the actin filament) to those forming the positively
charged ‘‘crown’’ in the VillinHP structure [3], namely K65, K71,
and F73, and implicated in the binding to F-actin [4]. Additionally,
the residue forming the ‘‘hydrophobic cap,’’ W64, can be provided
by P767 of Eps8, while L757 (which was mutated to A in Eps8 C-
terminus) is in the same structural position of the Phenylalanine at
position 76 of the VillinHP; mutation of the latter residue has been
shown to lower the binding to F-actin by more than 80% [4]. These
observationssuggestthat Eps8 andVillinmayindeedsharea similar
mode of interaction with actin filaments.
Found at: doi:10.1371/journal.pbio.1000387.s003 (0.44 MB TIF)
Figure S4 Hydrodynamic analysis of wild type and
GST-Eps8(648–821) mutants. (A) Size exclusion chromatog-
raphy (SEC) of the purified Eps8(648–821) wild type and the
various indicated mutants fused to GST was performed on
Superdex200 10/30. The elution profile of markers of defined
molecular weight is reported along with the profile of the various
Eps8(648–821) proteins detected by measuring the absorbance at
280 nm wavelength (graph) and by Comassie blue staining of
aliquots of eluted fractions resolved by SDS-PAGE (bottom
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1 h at room temperature (Red line and RT) or at 4uC (blue line)
with identical results. (B) Molecular weight determination of GST-
Eps8(648–821) through coupling of glycerol gradient cosedimen-
tation and gel filtration experiments. Left panels: Glycerol (10%–
40%) gradient sedimentation of markers of defined Svedberg
coefficient and of GST-Eps8(648–821). Coomassie blue staining of
aliquots of gradient fractions resolved by SDS-PAGE is shown.
Samples were loaded directly onto 5 ml 10%–40% glycerol
gradients (gradient buffer =100 mm Tris-HCl, pH 8, 500 mm
NaCl, 1 mm dithiothreitol, 1 mm EDTA). Centrifugation was
protracted for 13 h at 55,000 rpm on a Beckman SW41Ti
swinging bucket rotor at 4uC. The gradient was fractionated in
250 ml fractions. Bottom left graph: Sedimentation volume of the
markers (Bovine Pancreas Chymotrypsinogen albumine, aldolase,
and catalase) were plotted against their known Svedberg
coefficient (2,58S, 4,22S, 7,4S, and 11,4S, respectively) to generate
a calibration curve from which the Svedberg coefficient (s) of
GST-Eps8(648–821) was determined. Right panel: Superdex 200
elution profile of GST-Eps8(648–821) and of markers of known
Stoke radius. Bottom right graph: Elution volumes of the markers
(bovine thyroglobulin, rabbit aldolase, hen egg albumin, and
ribonuclease A) were plotted against their known Stokes radii to
generate a calibration curve (R
2=0.9775) from which the Stokes
radius of GST-Eps8(648–821) was determined. The molecular
weight was calculated from the Stokes radius (a) in A ˚ngstroms and
from s according to the equation molecular weight =a as [6],
where a=(6pg0N)/(1 2 nr), N is Avogadro’s number (6.02610
23),
g0 is the viscosity of medium (g/(cm?s)), r is the density of the
medium (g/ml), and n is the partial specific volume of the analyzed
particle (ml/g). Because g0 and r values change according to the
buffer composition and n depends on the amino acidic
composition, the a value was determined by plotting the molecular
weights of standard proteins against their a6s values. The axial
ratio of the prolate ellipsoid of rotation was calculated as described
[7]. Identical results were obtained for the GST-fused Eps8(648–
821) mutants.
Found at: doi:10.1371/journal.pbio.1000387.s004 (1.18 MB TIF)
Figure S5 Dimerization drives Eps8(648–821) bundling
activity. (A) The F-actin bundling ability of GST-Eps8-WT or
Eps8-WT GST cleaved was determined by co-sedimentation
assays. F-actin (1 mM) was incubated either alone or in the
presence of the indicated concentrations of GST, as control, or
GST-fused Eps8(648–821) or Eps8(648–821) cleaved from the
GST moiety. The mix was subjected to centrifugation at 10,000 g
for 30 min. Aliquots of the pellet (P) and supernatants (S) were
analyzed by immunoblotting with the abs indicated on the right.
Bar represents 5 mM. (B) F-actin (1 mM) was incubated with either
5 mM of GST, as control, or with the indicated concentration of
Eps8(648–821) cleaved from the GST moiety or GST-fused
Eps8(648–821). Actin filaments were labeled with rhodamine-
phalloidin and imaged using a fluorescence microscope as
previously described [5]. Data are representative fields acquired
with 1006 magnification. Three independent experiments per
condition were performed, all yielding similar results. Bar is 1 mM.
Found at: doi:10.1371/journal.pbio.1000387.s005 (2.15 MB TIF)
Figure S6 Immunofluorescence visualization of actin
bundles induced by wild type and GST-Eps8(648–821)
mutants. F-actin (1 mM) was incubated either alone (Actin) or
together with 5 mM of GST, as control, or with Eps8-WT or the
indicated Eps8 mutants fused to GST. Actin filaments were
labeled with rhodamine-phalloidin and imaged using a fluores-
cence microscope as previously described [5]. Data are represen-
tative fields of view acquired at 1006 magnification. For each
condition three independent experiments were performed yielding
similar results. Bar represents 5 mM.
Found at: doi:10.1371/journal.pbio.1000387.s006 (2.79 MB TIF)
Figure S7 Requirement of Eps8 capping activity for
optimal rocketing velocity of PIP2-rich endomem-
branes. (A) eps8-null MEFs co-microinjected with Myc–Phos-
phaditylinositol 4,5 kinase [PI(4,5)K], lifeact-cherry (a kind gift
from Roland Wedlich-Soldner) [8], and the indicated Eps8 mutant
fused to GFP or GFP alone, as control, were processed for
epifluorescence (A) or subjected to video microscopy (B). The first
frame of each representative video is show to visualize Cherry-
lifeact. The velocity of rocketing endomembranes was determined
by manually tracking individual vesicles in at least 5–10 different
cells using imageJ software. Data are shown as whisker plots, the
median, quartiles, and highest and lowest values are indicated;
** indicates HSD (honestly significant difference), alpha-value
,0.05, Turkey-Kramer HSD test. See also Videos S9–S13. Bar is
10 mm.
Found at: doi:10.1371/journal.pbio.1000387.s007 (3.34 MB TIF)
Figure S8 Differential requirement of Eps8 actin activ-
ities in architecturally diverse actin-based processes. (A)
Eps8 2/2 mouse embryo fibroblasts (MEFs) expressing GFP or
GFP-Eps8 (full length) or the indicated GFP-Eps8 mutants were
trypsinized, incubated with warm complete medium before plating
them on Fibronectin-coated cover slips. After 30 min cells were
fixed and counterstained with phalloidin to detect F-actin (red) and
the respective GFP-tagged protein (Green). Representative merged
images are shown. Magnified images corresponding to the boxed
insets on top panels are shown as merge (middle panels) or GFP
(lower panels, to evidence the localization of Eps8 and the various
Eps8 mutants). Red arrows point to microspikes; green arrowheads
indicatethe leadingedges of lamellipodia. Bar represents 10 mm. (B)
Mouse melanoma B16-F1 cells transfected with GFP-Eps8 WT or
the indicated mutants together with mCherry-actin [9] were plated
on laminin-coated cover slips and monitored by live-cell confocal
microscopy. Stills visualizing GFP constructs (top panels) or
mCherry-actin (middle panels) or both as merged images (bottom
panels) are shown. Red arrows point to microspikes; green
arrowheads indicate lamellipodia. Dual-color imaging using
488 nm multiline argon and 561 nm solid state lasers was done
on a Fluoview1000 confocal microscope equipped with a 1006/
1.45NA PlanApo TIRF objective (Olympus). Bars: 10 mM.
Found at: doi:10.1371/journal.pbio.1000387.s008 (7.00 MB TIF)
Figure S9 EPS-8 in C. elegans. (A) The critical residues
mediating barbed end and side binding of EPS8 are conserved in
the nematode homologue of EPS8 (Ce-EPS8). Sequence Align-
ment of the C-terminal region of human (Hs), mouse (Mm), and C.
elegans (Ce) Eps8. The organization into 5 a-helices is indicated on
top. Red and green stars indicate the conserved amino acids
required to mediate capping and bundling, respectively. Amino
acid positions are shown on right and left. (B) CeEPS8::GFP WT
and mutant protein expressed in the intestine display an apical-
restricted localization along the brush border. Photomicrographs
depicting intestinal morphology of eps-8(by160) heterozygous
worms expressing EPS-8 WT or (Dcap, Dbund, and DcapDbund)
under a gut specific promoter, opt-2. Fusion of the EPS-8
constructs to GFP allowed their visualization in epifluorescence
to evidence their restricted gut expression (upper panels).
Nomarski, epifluoresence, overlays of epifluorescence over No-
marski photomicrographs are also shown (proteins are in green).
Overlays of magnified boxed areas are shown at the bottom. Red
arrowheads indicate the intestinal lumen. Yellow arrows point to
Eps8 Caps and Bundles by Wrapping around F-Actin
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head pointing down or to the right. Bar: 10 mm. (C) Photomicro-
graphs depicting the apical localization of GFP::EPS-8 WT or
mutant proteins (Dcap, Dbund, and DcapDbund) arrays under a
gut specific promoter, opt-2 in DLG-1::RFP transgene expressing
worms. Intestinal sections in the merged epifluorescence green and
red channels (top) and overlays of epifluorescence channels over
Nomarski (bottom) photomicrographs are shown. Yellow boxed
insets are transversal Z sections of nematode intestines to visualize
the more luminal localization of WT EPS8::GFP and mutant
proteins with respect to DLG-1::RFP. Red arrowheads indicate
the intestinal lumen. Bar: 10 mm.
Found at: doi:10.1371/journal.pbio.1000387.s009 (6.30 MB TIF)
Text S1 Text S1 contains supplementary Materials and
Methods and supplementary References.
Found at: doi:10.1371/journal.pbio.1000387.s010 (0.07 MB
DOC)
Video S1 Actin Based motility in vitro assay in the
absence of capping proteins. Time-lapse phase-contrast
microscopy of in vitro actin-based motility assays performed
described in Figure S4D in the absence of capping proteins. Video
represents a time period of 20 min.
Found at: doi:10.1371/journal.pbio.1000387.s011 (0.21 MB AVI)
Video S2 Actin-based motility in vitro assay in the
presence of the capping protein Gelsolin. Time-lapse
phase-contrast microscopy of in vitro actin-based motility assays
performed described in Figure S4D in the presence of Gelsolin.
Video represents a time period of 20 min.
Found at: doi:10.1371/journal.pbio.1000387.s012 (0.21 MB AVI)
Video S3 Actin-based motility in vitro assay in the
presence of wild type EPS8(6482821). Time-lapse phase-
contrast microscopy of in vitro actin-based motility assays
performed described in Figure S4D in the presence of wild type
EPS8(6482821) (Eps8-WT). Video represents a time period of
20 min.
Found at: doi:10.1371/journal.pbio.1000387.s013 (0.47 MB AVI)
Video S4 Actin-based motility in vitro assay in the
presence of EPS8-Dbund mutant. Time-lapse phase-contrast
microscopy of in vitro actin-based motility assays performed
described in Figure S4D in the presence of EPS8-Dbund mutant.
Video represents a time period of 20 min.
Found at: doi:10.1371/journal.pbio.1000387.s014 (0.50 MB AVI)
Video S5 Actin-based motility in vitro assay in the
presence of EPS8-Dcap mutant. Time-lapse phase-contrast
microscopy of in vitro actin-based motility assays performed
described in Figure S4D in the presence of EPS8-Dcap mutant.
Video represents a time period of 20 min.
Found at: doi:10.1371/journal.pbio.1000387.s015 (0.18 MB AVI)
Video S6 Actin-based motility in vitro assay in the
presence of EPS8-Dcap Dbund mutant. Time-lapse phase-
contrast microscopy of in vitro actin-based motility assays
performed described in Figure S4D in the presence of EPS8-
Dcap Dbund mutant. Video represents a time period of 20 min.
Found at: doi:10.1371/journal.pbio.1000387.s016 (0.13 MB AVI)
Video S7 Actin-based motility in vitro assay in the
presence of H1–H2. Time-lapse phase-contrast microscopy of
in vitro actin-based motility assays performed described in Figure
S4D in the presence of H1–H2. Video represents a time period of
20 min.
Found at: doi:10.1371/journal.pbio.1000387.s017 (0.95 MB AVI)
Video S8 Actin-based motility in vitro assay in the
presence of H2–H5. Time-lapse phase-contrast microscopy of
in vitro actin-based motility assays performed described in Figure
S4D in the presence of H2–H5. Video represents a time period of
20 min.
Found at: doi:10.1371/journal.pbio.1000387.s018 (0.09 MB AVI)
Video S9 Propulsion rate of rocketing PIP2-rich vesicles
in the presence of EPS8(648–821). Time-lapse fluorescent
microscopy of PIP2-rich vesicles was performed as described in
Figure S5 by expressing PI4,5K together with EPS8(648–821)
(Eps8-WT). Only the dynamic of lifeact-cherry is shown to
facilitate the visualization of rocketing vesicles. Frames were taken
every 3.3 to 7.1 s for a total time period of 5 min using a Spinning
Disk confocal microscope Ultra VIEW VoX, Perkin Elmer 1006
objective, 1.49 N.A, Nikon TiEclipse.
Found at: doi:10.1371/journal.pbio.1000387.s019 (0.75 MB
MPG)
Video S10 Propulsion rate of rocketing PIP2-rich vesi-
cles in the presence of EPS8-Dbund. Time-lapse fluorescent
microscopy of PIP2-rich vesicles was performed as described in
Figure S5 by expressing PI4,5K together with EPS8-Dbund. Only
the dynamic of lifeact-cherry is shown to facilitate the visualization
of rocketing vesicles. Frames were taken every 3.3 to 7.1 s for a
total time period of 5 min using a Spinning Disk confocal
microscope Ultra VIEW VoX, Perkin Elmer 1006objective, 1.49
N.A, Nikon TiEclipse.
Found at: doi:10.1371/journal.pbio.1000387.s020 (1.08 MB AVI)
Video S11 Propulsion rate of rocketing PIP2-rich vesi-
cles in the presence of EPS8-Dcap. Time-lapse fluorescent
microscopy of PIP2-rich vesicles was performed as described in
Figure S5 by expressing PI4,5K together with Eps8-Dcap. Only
the dynamic of lifeact-cherry is shown to facilitate the visualization
of rocketing vesicles. Frames were taken every 3.3 to 7.1 s for a
total time period of 5 min using a Spinning Disk confocal
microscope Ultra VIEW VoX, Perkin Elmer 1006objective, 1.49
N.A, Nikon TiEclipse.
Found at: doi:10.1371/journal.pbio.1000387.s021 (0.83 MB AVI)
Video S12 Propulsion rate of rocketing PIP2-rich vesi-
cles in the presence of GFP. Time-lapse fluorescent
microscopy of PIP2-rich vesicles was performed as described in
Figure S5 by expressing PI4,5K together with GFP. Only the
dynamic of lifeact-cherry is shown to facilitate the visualization of
rocketing vesicles. Frames were taken every 3.3 to 7.1 s for a total
time period of 5 min using a Spinning Disk confocal microscope
Ultra VIEW VoX, Perkin Elmer 1006objective, 1.49 N.A, Nikon
TiEclipse.
Found at: doi:10.1371/journal.pbio.1000387.s022 (1.19 MB AVI)
Video S13 Propulsion rate of rocketing PIP2-rich vesi-
cles in the presence of EPS8-Dcap Dbund. Time-lapse
fluorescent microscopy of PIP2-rich vesicles was performed as
described in Figure S5 by expressing PI4,5K together with EPS8-
Dcap Dbund. Only the dynamic of lifeact-cherry is shown to
facilitate the visualization of rocketing vesicles. Frames were taken
every 3.3 to 7.1 s for a total time period of 5 min using a Spinning
Disk confocal microscope Ultra VIEW VoX, Perkin Elmer 1006
objective, 1.49 N.A, Nikon TiEclipse.
Found at: doi:10.1371/journal.pbio.1000387.s023 (0.48 MB AVI)
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